News2023-10-05T18:00:57+02:00

NEWS

Flora Binder to join Dillico as Chief Development Officer

We are pleased to announce today that Flora Binder has taken up her role of Dillico’s Chief Development Officer. “Flora has a solid expertise in mRNA process transfer in the global pharmaceutical industry and it will be a significant asset to Dillico to advance our vision to modernize mRNA-LNP manufacturing. On behalf of our team, I want to warmly welcome Flora as a new member of the management,” said Christophe Bonneville, [...]

1 March 2023|

French Tech Emergence Grant for Dillico

Dillico is pleased to announce that it has been awarded a French Tech Emergence grant by BPIFrance, which we thank. This financial support is granted to startup projects that develop a disruptive innovation with high technological content. It allows to conduct feasibility studies still needed. Dillico will use this [...]

30 January 2023|